NEW YORK · NAICS 31-33
New York manufacturing projects get the program's strongest fiscal 2026 economics, with 7(a) fees waived on loans up to $950,000, 504 fees waived entirely, and a $5.5 million debenture available. Studies translate capacity, throughput, customer concentration, and contract pipeline into defensible projections, and the file aligns equipment, real estate, and working capital with the right program structure.
FEASIBILITY TRIGGER
Fiscal 2026 gives manufacturers the strongest program economics, with 7(a) fees waived on loans up to $950,000, 504 fees waived entirely, and a $5.5 million debenture.
SBA 7(a) and 504 lenders funded 3,277 manufacturing projects across New York between FY2010 and FY2026, moving $1.41 billion in approved capital at an average ticket of $430,000. That volume places New York at #4 of 38 states measured for manufacturing SBA activity, or 3.6% of national manufacturing dollars. The 7(a) program carried 90.6% of the loan count, with 504 taking the balance, and 421 approvals have hit the pipeline since FY2024.
| Disbursed loans (FY2010–FY2026) | 3,277 |
| Approved volume | $1.41 billion |
| Average loan size | $430,000 |
| 7(a) share | 90.6% |
| Approvals since FY2024 | 421 |
| State rank by loan count | #4 of 38 |
Among the 2,566 seasoned loans in this segment (approvals FY2010–FY2021), 8.6% reached adverse resolution — purchased, liquidated, or charged off. The national benchmark for manufacturing is 6.6%, against 7.3% across all industries. That performance runs above the national benchmark for this asset class, which is a factor lenders weigh in their credit decision.
Source: SBA 7(a) and 504 FOIA loan-level data, as of March 31, 2026. Disbursed loans only. See data methodology.
A 8.6% adverse-resolution rate against the national manufacturing benchmark of 6.6% tells credit committees to scrutinize revenue projections and coverage assumptions closely on New York deals in this class. A rigorous third-party feasibility study — built on documented demand, defensible pricing, and stressed coverage — carries meaningful weight in that underwriting conversation, particularly at an average loan size of $430,000 across 3,277 loans.
Every New York manufacturing project we underwrite follows the same lender ready process: independent market analysis, site and technical review, and financial projections tested against SBA SOP 50 10 8 standards. Our SBA feasibility study consultants guide explains scope, timing, deliverables, and what lenders and CDCs expect in the report.
New York projects often fit SBA 504 where owner-occupied real estate anchors the deal, with the 50/40/10 structure delivering up to 90 percent financing at a fixed debenture rate, while SBA 7(a) covers acquisitions, working capital, and equipment. From July 4, 2026 eligible borrowers can combine 7(a) and 504 for up to $10 million in total program credit.
New York's upstate manufacturing base, including precision, food, and contract production, anchors deal flow in this class.
For a national view of this asset class, see our manufacturing SBA feasibility overview, and read our related analysis in the manufacturing lending research on our blog.
Compare neighboring markets: New Mexico, North Carolina, Texas.
Public SBA and CDC program records, cited as program evidence
SBA 504 through Capital CDC
Manufacturing facility, national program evidence
Bridgeport, Wise County, Texas
Fifteen-minute scoping call, written proposal inside one business day, firm fixed fee before you sign.
Book a Meeting